Objectives: This retrospective study used various indices to evaluate remission and low disease activity in ‘real life’ patients with rheumatoid arthritis (RA), given antitumour necrosis factor (anti-TNF) as a first-line treatment; changes in concomitant steroid and conventional synthetic disease-modifying antirheumatic drug (csDMARD) treatment were also assessed. Methods: Remission and low disease activity were analysed in patients with RA treated with anti-TNF using the 28-joint Disease Activity Score (DAS28), Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI). Remission and low disease activity were recorded after 6 months, 1 year and 2 years, along with concomitant prednisone and csDMARD treatment. Results: A total of 271 patients with RA were included in the study. After 6 months, remission rates were 18.0%, 20.3% and 23.0% as assessed by CDAI, SDAI and DAS28, respectively. After 1 year and 2 years, respectively, remission rates were 18.4% and 15.9% using CDAI, 21.8% and 17.3% using SDAI, and 22.1% and 17.3% using DAS28. Low disease activity was achieved in 30–40% of patients, depending on the indices used. There was a significant reduction in the number of patients on prednisone and csDMARDs during anti-TNF treatment. Conclusion: Remission with first-line anti-TNF treatment is an achievable goal in clinical practice, allowing a reduction in concomitant csDMARD and prednisone treatment.
Conigliaro, P., Chimenti, M.S., Triggianese, P., Ballanti, E., Sunzini, F., Duca, I., et al. (2016). Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 44(1_suppl), 90-94 [10.1177/0300060515593262].
Tipologia: | Articolo su rivista | |
Citazione: | Conigliaro, P., Chimenti, M.S., Triggianese, P., Ballanti, E., Sunzini, F., Duca, I., et al. (2016). Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 44(1_suppl), 90-94 [10.1177/0300060515593262]. | |
URL: | http://imr.sagepub.com/content/by/year | |
Lingua: | English | |
Settore Scientifico Disciplinare: | Settore MED/16 - Reumatologia | |
Revisione (peer review): | Esperti anonimi | |
Tipo: | Articolo | |
Rilevanza: | Rilevanza internazionale | |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1177/0300060515593262 | |
Stato di pubblicazione: | Pubblicato | |
Data di pubblicazione: | 2016 | |
Titolo: | Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor | |
Autori: | ||
Autori: | Conigliaro, P; Chimenti, MS; Triggianese, P; Ballanti, E; Sunzini, F; Duca, I; Perricone, R | |
Appare nelle tipologie: | 01 - Articolo su rivista |